Chagaleti BK - Search Results

1

Hydroxyl chalcone derivative DK02 as a multi-target-directed ligand for Alzheimer's disease: A preclinical study in zebrafish.

Haridevamuthu B, Bharti AK, Nayak SPRR, Narayanan D, Loganathan Sumathi D, Chagaleti BK, Saravanan V, Rajagopal R, Alfarhan A, Muthu Kumaradoss K, Arockiaraj J. Haridevamuthu B, et al. Among authors: chagaleti bk. Br J Pharmacol. 2024 Dec 22. doi: 10.1111/bph.17426. Online ahead of print. Br J Pharmacol. 2024. PMID: 39710579

2

Therapeutic Potential of Thiophene-Based Chalcone Analog Against Acrylamide-Induced Neurotoxicity and Osteotoxicity.

Haridevamuthu B, Madesh S, Bharti AK, Kumar A, Dhivya LS, Chagaleti BK, Rajagopal R, Alfarhan A, Kathiravan MK, Arockiaraj J. Haridevamuthu B, et al. Among authors: chagaleti bk. Mol Neurobiol. 2024 Dec 2. doi: 10.1007/s12035-024-04623-5. Online ahead of print. Mol Neurobiol. 2024. PMID: 39617840

3

1,5- diaryl pyrazole-loaded chitosan nanoparticles as COX-2 inhibitors, mitigate neoplastic growth by regulating NF-κB pathway in-vivo zebrafish model.

Murugan R, Selvam M, Haridevamuthu B, Ashok K, Chagaleti BK, Priya D, Rajagopal R, Alfarhan A, Kumaradoss KM, Arockiaraj J. Murugan R, et al. Among authors: chagaleti bk. Int J Biol Macromol. 2024 Dec;283(Pt 1):137599. doi: 10.1016/j.ijbiomac.2024.137599. Epub 2024 Nov 13. Int J Biol Macromol. 2024. PMID: 39542324

4

A novel brominated chalcone derivative as a promising multi-target inhibitor against multidrug-resistant Listeria monocytogenes.

Haridevamuthu B, Nayak SPRR, Madesh S, Dhivya LS, Chagaleti BK, Pasupuleti M, Rajakrishnan R, Alfarhan A, Muthu Kumaradoss K, Arockiaraj J. Haridevamuthu B, et al. Among authors: chagaleti bk. Microb Pathog. 2024 Nov;196:106968. doi: 10.1016/j.micpath.2024.106968. Epub 2024 Sep 21. Microb Pathog. 2024. PMID: 39307201

5

Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation - A systematic computational approach to discover novel cancer therapeutics.

Chagaleti BK, B SK, G V A, Rajagopal R, Alfarhan A, Arockiaraj J, Muthu Kumaradoss K, Karthick Raja Namasivayam S. Chagaleti BK, et al. Comput Biol Chem. 2024 Oct;112:108134. doi: 10.1016/j.compbiolchem.2024.108134. Epub 2024 Jun 25. Comput Biol Chem. 2024. PMID: 38964206 Review.

6

Anti-cancer properties of Sansalvamide A, its derivatives, and analogs: an updated review.

Chagaleti BK, Baby K, Peña-Corona SI, Leyva-Gómez G, S M S, Naveen NR, Jose J, Aldahish AA, Sharifi-Rad J, Calina D. Chagaleti BK, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7337-7351. doi: 10.1007/s00210-024-03129-0. Epub 2024 May 13. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38739152 Review.

7

Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX.

Saravanan V, Chagaleti BK, Packiapalavesam SD, Kathiravan M. Saravanan V, et al. Among authors: chagaleti bk. RSC Adv. 2024 Jan 22;14(5):3346-3358. doi: 10.1039/d3ra08618f. eCollection 2024 Jan 17. RSC Adv. 2024. PMID: 38259989 Free PMC article.

8

Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach.

Chagaleti BK, Saravanan V, Vellapandian C, Kathiravan MK. Chagaleti BK, et al. RSC Adv. 2023 Nov 17;13(48):33770-33785. doi: 10.1039/d3ra05672d. eCollection 2023 Nov 16. RSC Adv. 2023. PMID: 38019988 Free PMC article.

9

Discovery and development of COVID-19 vaccine from laboratory to clinic.

Saravanan V, Chagaleti BK, Narayanan PL, Anandan VB, Manoharan H, Anjana GV, Peraman R, Namasivayam SKR, Kavisri M, Arockiaraj J, Muthu Kumaradoss K, Moovendhan M. Saravanan V, et al. Among authors: chagaleti bk. Chem Biol Drug Des. 2024 Jan;103(1):e14383. doi: 10.1111/cbdd.14383. Epub 2023 Nov 13. Chem Biol Drug Des. 2024. PMID: 37953736 Review.

10

An overview of mechanism and chemical inhibitors of shikimate kinase.

Chagaleti BK, Reddy MBR, Saravanan V, B S, D P, Senthil Kumar P, Kathiravan MK. Chagaleti BK, et al. J Biomol Struct Dyn. 2023;41(23):14582-14598. doi: 10.1080/07391102.2023.2193985. Epub 2023 Mar 28. J Biomol Struct Dyn. 2023. PMID: 36974959 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters